CYTK - Cytokinetics, Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$113.33
DETAILS
HIGH:
$140.00
LOW:
$103.00
MEDIAN:
$112.00
CONSENSUS:
$113.33
UPSIDE:
80.29%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,048,103 | $89.3M | 0.0% | +1,007,403 | INCREASED |
| Greenblatt | 5,367 | $457,215 | 0.0% | +5,367 | NEW |
| Wood | 600 | $51,114 | 0.0% | -6,300 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-20 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $64.01 | $224K |
| 2026-10-20 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
| 2026-10-16 | Wysenski Nancy | director | A-Award | 97 | $63.92 | $6K |
| 2026-10-16 | Kaye Edward M. MD | director | A-Award | 195 | $63.92 | $12K |
| 2026-10-16 | Harrington Robert Arthur | director | A-Award | 195 | $63.92 | $12K |
| 2026-10-16 | Daly James M | director | A-Award | 195 | $63.92 | $12K |
| 2026-10-16 | WIERENGA WENDELL | director | A-Award | 97 | $63.92 | $6K |
| 2026-10-16 | HENDERSON JOHN T | director | A-Award | 352 | $63.92 | $22K |
| 2026-10-12 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-10-12 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $62.88 | $472K |
| 2026-10-06 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
| 2026-10-06 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $61.38 | $215K |
| 2026-09-28 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-09-28 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $65.46 | $491K |
| 2026-09-22 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $68.29 | $239K |
| 2026-09-22 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
| 2026-09-15 | Landry Robert E | director | SELL | 1,000 | $72.13 | $72K |
| 2026-09-14 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-09-14 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $73.44 | $551K |
| 2026-09-14 | Blum Robert I | director, officer: President & CEO | G-Gift | 1,350 | -- | -- |
| 2026-09-14 | Blum Robert I | director, officer: President & CEO | G-Gift | 97,926 | -- | -- |
| 2026-09-15 | Blum Robert I | director, officer: President & CEO | SELL | 97,926 | $69.33 | $6.8M |
| 2026-09-11 | Landry Robert E | director | SELL | 1,000 | $74.66 | $75K |
| 2026-09-08 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $75.46 | $264K |
| 2026-09-08 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-10-12 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |
| 2026-07-03 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |